Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership19,278 shares
Latest Disclosed Value $ 1,270,613
Victory Capital Management Inc reports 9.89% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 19,278 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $1,041,012 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 17,543 shares of Cytokinetics, Incorporated. This represents a change in shares of 9.89% during the quarter. The current value of the position is $1,201,405 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS COM 23282W605 19,278 1,735 9.89 1,271 14.00 0.0006
2026-02-13 2025-12-31 13F CYTOKINETICS COM 23282W605 17,543 -92 -0.52 1,115 14.96 0.0006
2025-11-12 2025-09-30 13F CYTOKINETICS COM 23282W605 17,635 -20,479 -53.73 969 -23.03 0.0006
2025-08-13 2025-06-30 13F CYTOKINETICS COM 23282W605 38,114 16,538 76.65 1,259 45.21 0.0008
2025-05-02 2025-03-31 13F CYTOKINETICS COM 23282W605 21,576 -140 -0.64 867 -15.08 0.0009
2025-02-06 2024-12-31 13F CYTOKINETICS COM 23282W605 21,716 -13,888 -39.01 1,022 -45.66 0.0010
2024-11-05 2024-09-30 13F CYTOKINETICS COM 23282W605 35,604 -1,435 -3.87 1,880 -6.33 0.0018
2024-08-05 2024-06-30 13F CYTOKINETICS COM 23282W605 37,039 3,436 10.23 2,007 -14.82 0.0020
2024-05-03 2024-03-31 13F CYTOKINETICS COM 23282W605 33,603 -158,051 -82.47 2,356 -85.28 0.0023
2024-02-05 2023-12-31 13F CYTOKINETICS COM 23282W605 191,654 174,848 1,040.39 16,001 3,132.53 0.0168
2023-11-06 2023-09-30 13F CYTOKINETICS COM 23282W605 16,806 1,091 6.94 495 -3.32 0.0006
2023-07-27 2023-06-30 13F CYTOKINETICS COM 23282W605 15,715 320 2.08 513 -5.36 0.0006
2023-05-02 2023-03-31 13F CYTOKINETICS COM 23282W605 15,395 -70,037 -81.98 542 -86.18 0.0006
2023-04-25 2022-12-31 13F/A-3 CYTOKINETICS COM 23282W605 85,432 -513,796 -85.74 3,914 -86.52 0.0045
2023-03-10 2022-12-31 13F/A-2 CYTOKINETICS COM 23282W605 85,432 -513,796 3,914 0.0043
2023-02-10 2022-12-31 13F/A-1 CYTOKINETICS COM 23282W605 85,432 -513,796 3,914 0.0000
2023-02-09 2022-12-31 13F CYTOKINETICS COM 23282W605 69,416 -529,812 3,117 0.0021
2022-11-02 2022-09-30 13F CYTOKINETICS COM 23282W605 599,228 523,279 688.99 29,032 872.92 0.0339
2022-08-01 2022-06-30 13F CYTOKINETICS COM 23282W605 75,949 52,886 229.31 2,984 224.35 0.0034
2022-05-04 2022-03-31 13F CYTOKINETICS COM 23282W605 23,063 14,398 166.16 920 132.91 0.0009
2022-02-07 2021-12-31 13F CYTOKINETICS COM 23282W605 8,665 -1,106 -11.32 395 13.18 0.0004
2021-11-02 2021-09-30 13F CYTOKINETICS COM 23282W605 9,771 9,771 349 0.0003
2021-08-03 2021-06-30 13F CYTOKINETICS COM 23282W605 0 -9,933 -100.00 0 -100.00
2021-05-04 2021-03-31 13F CYTOKINETICS COM 23282W605 9,933 1,848 22.86 231 143.16 0.0002
2020-05-12 2020-03-31 13F/A-1 CYTOKINETICS COM 23282W605 8,085 -3,286 -28.90 95 -21.49 0.0002
2020-05-04 2020-03-31 13F CYTOKINETICS COM 23282W605 8,085 -3,286 95 103.9678
2020-02-06 2019-12-31 13F/A-1 CYTOKINETICS COM 23282W605 11,371 3,057 36.77 121 27.37 0.0001
2020-02-04 2019-12-31 13F CYTOKINETICS COM 23282W605 8,270 -44 102 122.2664
2019-11-12 2019-09-30 13F CYTOKINETICS COM 23282W605 8,314 8,314 95 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.